Merck (MRK) Reports In-Line Q4; Guides In-Line
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $128.66 +2.56%
Revenue Growth %: +3.5%
Financial Fact:
Materials and production: 5.59B
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +3.5%
Financial Fact:
Materials and production: 5.59B
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q4 EPS of $0.89, versus the consensus of $0.89. Revenue for the quarter came in at $10.1 billion, versus $10.22 billion consensus.
GUIDANCE:
Merck sees FY2017 EPS of $3.72-$3.87, versus the consensus of $3.85.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
- Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
- BlackBerry (BB) Tops Q1 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
